Research Article

Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma

Table 1

Clinicopathological characteristics between three clusters in TCGA cohort.

CharacteristicsCluster 1 (n, %)Cluster 2 (n, %)Cluster 3 (n, %) value

Age0.348
 >6562 (36.9%)66 (36.1%)54 (30.2%)
 ≤65106 (63.1%)117 (63.9%)125 (69.8%)
Gender0.574
 Male110 (65.5%)123 (67.2%)111 (62%)
 Female58 (34.5%)60 (32.8%)68 (38%)
T stage0.116
 T192 (54.6%)84 (45.9%)85 (53.1%)
 T217 (10.1%)23 (12.6%)29 (16.2%)
 T354 (33.5%)70 (38.2)53 (29.6%)
 T43 (1.8%)6 (3.3%)2 (1.1%)
N stage0.281
 N083 (49.4%)76 (41.5%)80 (44.7%)
 N13 (1.8%)9 (4.9%)4 (2.2%)
 Nx82 (48.8%)98 (53.6%)95 (53.1%)
M stage0.521
 M0140 (83.3%)146 (79.8%)154 (86%)
 M124 (14.3%)34 (18.6%)22 (12.3%)
 Mx4 (2.4%)3 (1.6%)3 (1.7%)
AJCC stage0.059
 Stage I90 (53.6%)81 (44.3%)95 (53.1%)
 Stage II13 (7.7%)17 (9.3%)27 (15.1%)
 Stage III40 (23.8%)49 (26.8%)35 (19.6%)
 Stage IV25 (14.9%)36 (19.7%)22 (12.3%)
Grade0.024
 G14 (2.4%)3 (1.6%)7 (3.9%)
 G260 (35.7%)76 (41.5%)93 (52%)
 G378 (46.4%)70 (38.3%)59 (33%)
 G425 (14.9%)33 (18%)17 (9.5%)
 Gx1 (0.6%)1 (0.5%)3 (0.9%)